Results 291 to 300 of about 213,470 (338)

Loss of hepatic autophagy induces α-cell proliferation through impaired glutamine-dependent gluconeogenesis. [PDF]

Physiol Rep
Velasco-Silva JN, Wilkerson JL, Ramos D, Low HK, Bowman F, Evason KJ, Boudina S, Holland WL, Ducker GS.   +8 more
europepmc   +1 more source

Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study.

BMJ
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Glucagon receptors

Cellular and Molecular Life Sciences, 2008
Glucagon is a pancreatic peptide hormone that, as a counterregulatory hormone for insulin, stimulates glucose release by the liver and maintains glucose homeostasis. First described as a glucagon binding entity functionally linked to adenylyl cyclase, the glucagon receptor is a member of the family B receptors within the G protein coupled superfamily ...
Authier, François, Desbuquois, Bernard
openaire   +4 more sources

Glucagon and the Glucagon-Like Peptides

Pancreas, 1990
Glucagon and the glucagon-like peptides are encoded within a larger precursor, proglucagon. The proglucagon gene is expressed in the pancreas, intestine, and brain, giving rise to a single proglucagon mRNA transcript that is identical in all tissues. Tissue-specific posttranslational processing of proglucagon accounts for the different molecular forms ...
openaire   +4 more sources

Glucagon

Emergency Medicine, 2003
AbstractDespite its infrequent usage, glucagon is an important drug in the ED. It has both well established and less well established indications. This article reviews its role for the practising emergency physician.
openaire   +2 more sources